Company performance
Add to research
Current Price
as of Feb 14, 2025$72.72
P/E Ratio
57.83
Market Cap
$7.62B
Description
Add to research
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Metrics
Add to research
Overview
- HQRedwood City, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCORT
- Price$72.72-1.21%
Trading Information
- Market cap$7.62B
- Float85.98%
- Average Daily Volume (1m)922,015
- Average Daily Volume (3m)833,859
- EPS$1.36
Company
- Revenue$628.56M
- Rev growth (1yr)47.69%
- Net income$46.69M
- Gross margin98.43%
- EBITDA margin25.80%
- EBITDA$47.10M
- EV$4.89B
- EV/Revenue7.78
- P/E57.83
- P/S13.16
- P/B11.92
- Debt/Equity1.06
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset